Cooper ROE 2010-2024 | COO
Current and historical return on equity (ROE) values for Cooper (COO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Cooper ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2024-01-31 |
$0.29B |
$7.70B |
3.86% |
| 2023-10-31 |
$0.30B |
$7.55B |
3.96% |
| 2023-07-31 |
$0.28B |
$7.53B |
3.75% |
| 2023-04-30 |
$0.29B |
$7.38B |
3.99% |
| 2023-01-31 |
$0.38B |
$7.34B |
5.26% |
| 2022-10-31 |
$0.39B |
$7.18B |
5.48% |
| 2022-07-31 |
$0.43B |
$7.08B |
6.15% |
| 2022-04-30 |
$0.95B |
$7.01B |
13.71% |
| 2022-01-31 |
$0.94B |
$6.93B |
14.01% |
| 2021-10-31 |
$2.95B |
$6.94B |
45.52% |
| 2021-07-31 |
$2.92B |
$6.79B |
51.24% |
| 2021-04-30 |
$2.36B |
$6.16B |
47.73% |
| 2021-01-31 |
$2.25B |
$5.99B |
52.29% |
| 2020-10-31 |
$0.24B |
$3.83B |
6.40% |
| 2020-07-31 |
$0.28B |
$3.76B |
7.57% |
| 2020-04-30 |
$0.34B |
$3.63B |
9.42% |
| 2020-01-31 |
$0.45B |
$3.73B |
12.51% |
| 2019-10-31 |
$0.47B |
$3.63B |
13.11% |
| 2019-07-31 |
$0.45B |
$3.62B |
12.84% |
| 2019-04-30 |
$0.43B |
$3.54B |
12.65% |
| 2019-01-31 |
$0.37B |
$3.43B |
11.13% |
| 2018-10-31 |
$0.14B |
$3.31B |
4.35% |
| 2018-07-31 |
$0.13B |
$3.23B |
4.02% |
| 2018-04-30 |
$0.13B |
$3.19B |
4.15% |
| 2018-01-31 |
$0.18B |
$3.16B |
5.66% |
| 2017-10-31 |
$0.37B |
$3.18B |
12.44% |
| 2017-07-31 |
$0.35B |
$3.09B |
11.98% |
| 2017-04-30 |
$0.33B |
$2.94B |
11.79% |
| 2017-01-31 |
$0.30B |
$2.82B |
10.88% |
| 2016-10-31 |
$0.27B |
$2.70B |
10.16% |
| 2016-07-31 |
$0.25B |
$2.74B |
9.29% |
| 2016-04-30 |
$0.21B |
$2.75B |
7.72% |
| 2016-01-31 |
$0.19B |
$2.61B |
7.33% |
| 2015-10-31 |
$0.20B |
$2.67B |
7.77% |
| 2015-07-31 |
$0.20B |
$2.69B |
7.60% |
| 2015-04-30 |
$0.24B |
$2.62B |
9.27% |
| 2015-01-31 |
$0.26B |
$2.52B |
10.02% |
| 2014-10-31 |
$0.27B |
$2.59B |
10.51% |
| 2014-07-31 |
$0.30B |
$2.68B |
11.71% |
| 2014-04-30 |
$0.30B |
$2.56B |
12.03% |
| 2014-01-31 |
$0.29B |
$2.45B |
12.14% |
| 2013-10-31 |
$0.30B |
$2.42B |
12.53% |
| 2013-07-31 |
$0.31B |
$2.44B |
13.47% |
| 2013-04-30 |
$0.29B |
$2.34B |
12.99% |
| 2013-01-31 |
$0.27B |
$2.25B |
12.51% |
| 2012-10-31 |
$0.25B |
$2.21B |
12.02% |
| 2012-07-31 |
$0.23B |
$2.10B |
11.69% |
| 2012-04-30 |
$0.21B |
$2.04B |
10.82% |
| 2012-01-31 |
$0.19B |
$1.94B |
10.09% |
| 2011-10-31 |
$0.18B |
$1.94B |
9.51% |
| 2011-07-31 |
$0.17B |
$1.89B |
9.37% |
| 2011-04-30 |
$0.16B |
$1.81B |
9.54% |
| 2011-01-31 |
$0.13B |
$1.72B |
8.03% |
| 2010-10-31 |
$0.11B |
$1.67B |
7.05% |
| 2010-07-31 |
$0.09B |
$1.59B |
6.04% |
| 2010-04-30 |
$0.08B |
$1.54B |
4.94% |
| 2010-01-31 |
$0.10B |
$1.55B |
6.43% |
| 2009-10-31 |
$0.10B |
$1.54B |
6.89% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$17.657B |
$3.593B |
|
The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians.
|
